D. I. Fedoseenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
D. I. Fedoseenko has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
A. V. Nazarenko
Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation
1 shared publication- Denis I. Sofronov
N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia
1 shared publication - Denis Sergeevich Romanov
Center for Innovative Medical Technologies
1 shared publication - E. R. Musaev
Ministry of Health of the Russian Federation, Moscow, Russian Federation
1 shared publication - E. S. Makarov
ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России
1 shared publication G. A. Tkachenko
ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России
1 shared publication
Latest Publications
- Open Access
- 3 April 2020
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 3 (1) , 11-20
Remote Radiotherapy in the Treatment of Patients with Perivascular Epithelial Cell Tumors
The main method of treating rare mesenchymal tumors PEComas is surgical removal of the tumor and external-beam radiation therapy has historically been considered ineffective. However, the individual cases in the foreign literature as well as this article authors’ experience in the form of the clinical case provided in it shows the possibility of achieving some anti-tumor effect due to the use of aggressive variants of radiation therapy. The use of variations of stereotactic radiotherapy with high dose per fraction and sum dose as an neoadjuvant and definitive treatment looks promising.
- 3 April 2020
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 3 (1) , 11-20
Open AccessRemote Radiotherapy in the Treatment of Patients with Perivascular Epithelial Cell Tumors
The main method of treating rare mesenchymal tumors PEComas is surgical removal of the tumor and external-beam radiation therapy has historically been considered ineffective. However, the individual cases in the foreign literature as well as this article authors’ experience in the form of the clinical case provided in it shows the possibility of achieving some anti-tumor effect due to the use of aggressive variants of radiation therapy. The use of variations of stereotactic radiotherapy with high dose per fraction and sum dose as an neoadjuvant and definitive treatment looks promising.
- Open Access
- 1 January 2017
- Published by Russian Society of Clinical Oncology in Malignant tumours
- Vol. 7 (4) , 5-12
RADIOTHERAPY AFTER ORGAN-SPARING SURGERY FOR I-IIA STAGES OF LEFT-SIDED BREAST CANCER
ЛУЧЕВАЯ ТЕРАПИЯ БОЛЬНЫХ РАКОМ ЛЕВОЙ МОЛОЧНОЙ ЖЕЛЕЗЫ I-IIA СТАДИЙ ПОСЛЕ ОРГАНОСОХРАНЯЮЩИХ ОПЕРАЦИЙ
- 1 January 2017
- Published by Russian Society of Clinical Oncology in Malignant tumours
- Vol. 7 (4) , 5-12
Open AccessRADIOTHERAPY AFTER ORGAN-SPARING SURGERY FOR I-IIA STAGES OF LEFT-SIDED BREAST CANCER
ЛУЧЕВАЯ ТЕРАПИЯ БОЛЬНЫХ РАКОМ ЛЕВОЙ МОЛОЧНОЙ ЖЕЛЕЗЫ I-IIA СТАДИЙ ПОСЛЕ ОРГАНОСОХРАНЯЮЩИХ ОПЕРАЦИЙ